Advertisement

Lung

, Volume 191, Issue 4, pp 345–351 | Cite as

Angiotensin-Converting Enzyme (ACE) Gene Polymorphisms are Associated with Idiopathic Pulmonary Fibrosis

  • Soo-Taek Uh
  • Tae-Hoon Kim
  • Eun-Young Shim
  • An-Soo Jang
  • Sung-Woo Park
  • Jong-Sook Park
  • Byung-Lae Park
  • Byoung Whui Choi
  • Hyoung Doo Shin
  • Dong Soon Kim
  • Choon-Sik Park
Article

Abstract

Background

Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea and worsening lung function. ACE is increased in the bronchoalveolar lavage fluid from patients with IPF, suggesting the role of ACE in the pathogenesis of IPF. We evaluated the role of single-nucleotide polymorphisms (SNPs) in the development risk of IPF.

Methods

Two-hundred twenty patients with IPF and 456 healthy subjects were included in this study. Eleven polymorphisms were selected among those reported previously. Genotype was performed by single base extension.

Results

Although absolute LD (|D′| = 1 and r = 1) was not present, 11 SNPs showed tight LDs. The logistic analysis of the all of 11 SNPs on the ACE genes between patients with IPF and healthy subjects were found to be related with the risk of IPF in recessive type. However, in patients with IPF diagnosed by surgical lung biopsy, only two SNP of −5538T>C and +21288_insdel SNPs were related with the risk of IPF in co-dominant type, and there were no SNPs related with the risk of IPF in dominant type. In patients with IPF diagnosed by clinical criteria or surgical lung biopsy, four SNPs on promoter (−5538T>C, −5508A>C, −3927T>C, −115T>C), one on intron (+15276A>G), one on exon (+21181G>A), and one in three prime region (+21288_insdel) were related with the risk of IPF.

Conclusions

This study showed a newly discovered SNP of ACE associated with the risk of development of IPF. ACE −5538T>C and −5508A>C significantly associated with risk of IPF in Korea.

Keywords

Angiotensin-converting enzyme Genetic polymorphism Genotype Pulmonary fibrosis SNPs 

Notes

Acknowledgments

The DNA samples were generously provided by the Soonchunhyang University, Bucheon Hospital Biobank, a member of the National Biobank of Korea, supported by the Ministry of Health, Welfare and Family Affairs, Republic of Korea (Approval No. SCHBC-IRB-06-05). The English in this manuscript has been checked by textcheck (www.textcheck.com/certificate/RfXz47).

Conflict of interest

The authors declare that they have no conflicts of interest.

Supplementary material

408_2013_9469_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 16 kb)

References

  1. 1.
    American Thoracic Society/European Respiratory Society (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304CrossRefGoogle Scholar
  2. 2.
    Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525PubMedCrossRefGoogle Scholar
  3. 3.
    Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134:136–151PubMedCrossRefGoogle Scholar
  4. 4.
    Hodgson U, Laitinen T, Tukiainen P (2002) Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 57:338–342PubMedCrossRefGoogle Scholar
  5. 5.
    Marshall RP, Puddicombe A, Cookson WO, Laurent GJ (2000) Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 55:143–146PubMedCrossRefGoogle Scholar
  6. 6.
    Ward PA, Hunninghake GW (1998) Lung inflammation and fibrosis. Am J Respir Crit Care Med 157:S123–S129PubMedCrossRefGoogle Scholar
  7. 7.
    Gur I, Or R, Segel MJ, Shriki M, Izbicki G, Breuer R (2000) Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice. Exp Lung Res 26:521–534PubMedCrossRefGoogle Scholar
  8. 8.
    Oi M, Yamamoto T, Nishioka K (2004) Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-’susceptible’ mouse strains. J Med Dent Sci 51:7–17PubMedGoogle Scholar
  9. 9.
    Checa M, Ruiz V, Montano M, Velazquez-Cruz R, Selman M, Pardo A (2008) MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet 124:465–472PubMedCrossRefGoogle Scholar
  10. 10.
    Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S, Ogura T, Taniguchi H, Kubo M, Kamatani N, Nakamura Y (2008) A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 45:654–656PubMedCrossRefGoogle Scholar
  11. 11.
    Tsutsumi T, Nagai S, Imai K, Setoyama Y, Uchiyama T, Izumi T (1994) Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis 11:102–109PubMedGoogle Scholar
  12. 12.
    Jones HA, Schofield JB, Krausz T, Boobis AR, Haslett C (1998) Pulmonary fibrosis correlates with duration of tissue neutrophil activation. Am J Respir Crit Care Med 158:620–628PubMedCrossRefGoogle Scholar
  13. 13.
    Yoshiji H, Kuriyama S, Noguchi R, Fukui H (2004) Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy. Curr Cancer Drug Targets 4:555–567PubMedCrossRefGoogle Scholar
  14. 14.
    Morrison CD, Papp AC, Hejmanowski AQ, Addis VM, Prior TW (2001) Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum Pathol 32:521–528PubMedCrossRefGoogle Scholar
  15. 15.
    Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301–1315PubMedCrossRefGoogle Scholar
  16. 16.
    Travis WD, Matsui K, Moss J, Ferrans VJ (2000) Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24:19–33PubMedCrossRefGoogle Scholar
  17. 17.
    Ferris BG (1978) Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 118:1–120PubMedGoogle Scholar
  18. 18.
    Kim TH, Chang HS, Park SM, Nam BY, Park JS, Rhim T, Park HS, Kim MK, Choi IS, Cho SH, Chung IY, Park BL, Park CS, Shin HD (2008) Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 38:1727–1737PubMedGoogle Scholar
  19. 19.
    Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F (1996) Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 58:1268–1278PubMedGoogle Scholar
  20. 20.
    Shin HD, Park BL, Kim LH, Jung JH, Wang HJ, Kim YJ, Park HS, Hong SJ, Choi BW, Kim DJ, Park CS (2004) Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. Hum Mol Genet 13:397–403PubMedCrossRefGoogle Scholar
  21. 21.
    Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, Duan J, Carr JL, Lee MS, Koshy B, Kumar AM, Zhang G, Newell WR, Windemuth A, Xu C, Kalbfleisch TS, Shaner SL, Arnold K, Schulz V, Drysdale CM, Nandabalan K, Judson RS, Ruano G, Vovis GF (2001) Haplotype variation and linkage disequilibrium in 313 human genes. Science 293:489–493PubMedCrossRefGoogle Scholar
  22. 22.
    Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ (2004) Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 126:438–446PubMedCrossRefGoogle Scholar
  23. 23.
    Uhal BD, Kim JK, Li X, Molina-Molina M (2007) Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr Pharm Des 13:1247–1256PubMedCrossRefGoogle Scholar
  24. 24.
    Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174:810–816PubMedCrossRefGoogle Scholar
  25. 25.
    Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, du Bois RM (2003) Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in idiopathic pulmonary fibrosis. Respir Res 4:6PubMedCrossRefGoogle Scholar
  26. 26.
    Selman M, Lin HM, Montano M, Jenkins AL, Estrada A, Lin Z, Wang G, DiAngelo SL, Guo X, Umstead TM, Lang CM, Pardo A, Phelps DS, Floros J (2003) Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113:542–550PubMedCrossRefGoogle Scholar
  27. 27.
    Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, Uhal BD (2008) Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 295:L178–L185PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Soo-Taek Uh
    • 2
  • Tae-Hoon Kim
    • 1
  • Eun-Young Shim
    • 1
  • An-Soo Jang
    • 1
  • Sung-Woo Park
    • 1
  • Jong-Sook Park
    • 1
  • Byung-Lae Park
    • 3
  • Byoung Whui Choi
    • 4
  • Hyoung Doo Shin
    • 3
    • 5
  • Dong Soon Kim
    • 6
  • Choon-Sik Park
    • 1
    • 7
  1. 1.Genome Research Center for Allergy and Respiratory DiseasesSoonchunhyang University Bucheon HospitalBucheonSouth Korea
  2. 2.Division of Allergy and Respiratory MedicineSoonchunhyang University Seoul HospitalSeoulSouth Korea
  3. 3.Department of Genetic EpidemiologySNP-Genetics Inc.SeoulSouth Korea
  4. 4.Department of Internal MedicineChung Ang University College of MedicineSeoulSouth Korea
  5. 5.Department of Life ScienceSogang UniversitySeoulSouth Korea
  6. 6.Division of Pulmonary and Critical Care Medicine, Asan Medical CenterUniversity of UlsanSeoulSouth Korea
  7. 7.Division of Allergy and Respiratory Medicine, Department of Internal MedicineSoonchunhyang University Bucheon HospitalBucheonSouth Korea

Personalised recommendations